7 terminated. 7 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 7 | Terminated 7 |
| Phase 2 | 2 | Terminated 2 |
Follow Acute Ischemic Stroke: new trials by email Literature Review of Acute Ischemic Stroke trials Research Report on Acute Ischemic Stroke
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparing Between CO2 and Phenylephrine Treatment in Patients With Progressive Lacunar Infarction (CARBOGEN Study) carbogen, phenylephrine - Acute Ischemic Stroke | Phase 3 | Terminated | Yonsei University | 3 | 2021-04-05 | 2025-01-14 |
| DLBS1033 for Acute Ischemic Stroke Patients DLBS1033, Placebo - Acute Ischemic Stroke, Partial Anterior Circulation Infarct | Phase 2 / Phase 3 | Terminated | Dexa Medica Group | 80 | 2014-11-11 | 2023-12-12 |
| DLBS1033 for the Treatment of Acute Ischemic Stroke Placebo, DLBS1033 - Acute Ischemic Stroke | Phase 3 | Terminated | Dexa Medica Group | 9 | 2014-10-01 | 2017-05-04 |
| Cooling Plus Best Medical Treatment Versus Best Medical Treatment Alone for Acute Ischaemic Stroke Hypothermia, Buspirone, Pethidine - Acute Ischemic Stroke | Phase 3 | Terminated | University of Erlangen-Nürnberg Medical School | 98 | 2013-07-01 | 2019-10-02 |
| Phase 3, Randomized, Placebo-Controlled, Double-Blinded Trial of the Combined Lysis of Thrombus With Ultrasound and Systemic Tissue Plasminogen Activator (tPA) for Emergent Revascularization in Acute Ischemic Stroke Transcranial ultrasound as an adjunctive therapy to tPA, Standard of care tPA therapy for acute ischemic stroke - Acute Ischemic Stroke | Phase 3 | Terminated | Cerevast Therapeutics, Inc. | 675 | 2013-05-01 | 2015-04-07 |
| Hypothermia in Acute Stroke With Thrombolysis Imaging Evaluation of Revascularization IV t-PA and normothermia, IV-tPA and hypothermia - Acute Ischemic Stroke | Phase 2 / Phase 3 | Terminated | University of California, Los Angeles | 6 | 2013-02-01 | 2017-04-13 |
| Efficacy and Safety Study of DP-b99 in Treating Acute Ischemic Stroke DP-b99, Placebo - Acute Ischemic Stroke | Phase 3 | Terminated | D-Pharm Ltd. | 446 | 2009-12-01 | 2012-10-24 |
Ischemic Stroke (7) · Hypothermia (2) · Stroke (1) · Stroke, Lacunar (1)
Brain Diseases (7) · Cardiovascular Diseases (7) · Central Nervous System Diseases (7) · Cerebrovascular Disorders (7) · Nervous System Diseases (7) · Vascular Diseases (7) · Stroke (6) · Pathological Conditions, Signs and Symptoms (3) · Body Temperature Changes (2) · Signs and Symptoms (2) · Brain Infarction (1) · Cerebral Small Vessel Diseases (1) · Infarction (1) · Ischemia (1) · Necrosis (1)
DLBS 1033 (2) · Buspirone (1) · DP-b99 (1) · Meperidine (1) · Phenylephrine (1) · Standard of Care (1) · carbogen (1)
Dexa Medica Group (2) · Cerevast Therapeutics, Inc. (1) · D-Pharm Ltd. (1) · University of California, Los Angeles (1) · University of Erlangen-Nürnberg Medical School (1) · Yonsei University (1)
United States (3) · Germany (2) · Indonesia (2) · South Korea (2) · Austria (1) · Brazil (1) · Canada (1) · Czechia (1) · France (1) · Hungary (1) · Israel (1) · Italy (1) · Netherlands (1) · Poland (1) · Portugal (1)
Ashfaq Shuaib, MD (1) · David S Liebeskind, MD (1) · Diah H Soeryaningtias, Sp.S, MD (1) · Dian Cahyani, Sp.S, MD (1) · Dodik Tugasworo, Sp.S(K), MD (1) · Gotot S PW, Sp.S, MD (1) · Hanindia R. Prabaningtyas, Sp.S(K), MD (1) · Hugues Chabriat, Prof. (1) · Hyo Suk Nam, MD, PhD (1) · Ika Y Margaretha, Sp.S, MD (1) · Maria S Rocha, MD (1) · Muh. Hamdan, Sp.S(K), MD (1) · Paulus Sugianto, Sp.S(K), Dr, MD (1) · Philippe Lyrer, Prof. Dr. (1) · Rivan Danuaji, Sp.N(K), MD (1)
PMID 24828363, PMID 26120902, PMID 29187242, PMID 30878103
R01NS077706 (1)